JNJ vs VRTX
By Alex · Tickerpine
Johnson & Johnson vs Vertex Pharmaceuticals Incorporated, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | VRTX |
|---|---|---|
| Price | $263.81 | $523.93 |
| Market cap | $635.07B | $132.80B |
| P/E ratio | 40.0 | 29.9 |
| ROE | 20.02% | 23.54% |
| Profit margin | 16.20% | 35.00% |
| Revenue growth | 5.90% | 12.50% |
| Dividend yield | 2.03% | 0.00% |
| Beta | 0.21 | 0.28 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs VRTX in plain English
- JNJ is the bigger company — about 4.8× the market cap of VRTX.
- VRTX is cheaper on earnings (P/E 29.9 vs 40.0).
- VRTX earns a higher return on equity (24% vs 20%).
- VRTX is growing revenue faster (12% vs 6%).
- JNJ pays a dividend (2.03%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
VRTX return calculator
See what $1,000 in Vertex Pharmaceuticals Incorporated would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.